VENUSREMNSEVenus Remedies Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 24 Jun · 10:39 IST

Venus Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

VENUSREM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Venus Remedies has informed the stock exchanges that its trading window will be closed from July 1, 2025 until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2025. This is a standard regulatory requirement under SEBI's Insider Trading Regulations, 2015. The closure applies to all designated persons of the company, including insiders and employees with access to unpublished price-sensitive information. The communication was signed by Neha, Company Secretary, on June 24, 2025.

Likely market impact

This is a routine compliance filing and does not directly affect shareholders. However, it signals that Venus Remedies is preparing to announce its Q1 FY26 (April–June 2025) results soon, which investors should watch for as it may influence short-term stock movement.